mdwhittier, It seems CG had a grasp on everything except the FDA response (as salesman). He has positioned DMD $ Srpt very well with platform and manufacturing. The FDA is above pressure from parents and SRPT. But not above buffoonery with science and other interests. Whoever, whenever the FDA opens up will be a CEO of importance and accolades (Per Burger).
I wonder if this has to do with the workshop, with people speaking out for a drug approval at a science meeting? Pushed FDA over the top with Push for approval and accusations of conflict of interest of one of the speakers (Hoffman the quack). FDA told SRPT to eat dirt.
I can't help but think that they will use this same fellow in the EU RNA patent case where they claim to own the target of the splice. He is a Target expert not a skipping expert. He may be of use for broad target cases.